Rayjean J Hung, Elham Khodayari Moez, Shana J Kim, Sanjeev Budhathoki, Jennifer D Brooks
{"title":"Considerations of biomarker application for cancer continuum in the era of precision medicine.","authors":"Rayjean J Hung, Elham Khodayari Moez, Shana J Kim, Sanjeev Budhathoki, Jennifer D Brooks","doi":"10.1007/s40471-022-00295-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of the review: </strong>The goal of this review is to highlight emerging biomarker research by the key phases of the cancer continuum and outline the methodological considerations for biomarker application.</p><p><strong>Recent findings: </strong>While biomarkers have an established role in targeted therapy and to some extent, disease monitoring, their role in early detection and survivorship remains to be elucidated. With the advent of omics technology, the discovery of biomarkers has been accelerated exponentially, therefore careful consideration to ensure an unbiased study design and robust validity is crucial.</p><p><strong>Summary: </strong>The rigor of biomarker research holds the key to the success of precision health care. The potential clinical utility and the feasibility of implementation should be central to future biomarker research study design.</p>","PeriodicalId":48527,"journal":{"name":"Current Epidemiology Reports","volume":" ","pages":"200-211"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454320/pdf/nihms-1825288.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Epidemiology Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s40471-022-00295-8","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/7/9 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose of the review: The goal of this review is to highlight emerging biomarker research by the key phases of the cancer continuum and outline the methodological considerations for biomarker application.
Recent findings: While biomarkers have an established role in targeted therapy and to some extent, disease monitoring, their role in early detection and survivorship remains to be elucidated. With the advent of omics technology, the discovery of biomarkers has been accelerated exponentially, therefore careful consideration to ensure an unbiased study design and robust validity is crucial.
Summary: The rigor of biomarker research holds the key to the success of precision health care. The potential clinical utility and the feasibility of implementation should be central to future biomarker research study design.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
